Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 14, 2008 Anders Bylund	3 Stocks That Missed the Mark These companies overpromised and underdelivered: Alcoa... Rite Aid... GE...
The Motley Fool September 27, 2007 Ryan Fuhrmann	Rite Aid Looks a Little Peaked Bigger doesn't necessarily mean better for the drugstore retailer; it has quite a bit of work to do to convince investors it can successfully manage the empire that it has acquired.
The Motley Fool June 29, 2007 Ryan Fuhrmann	Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note.
The Motley Fool August 26, 2008 Rick Aristotle Munarriz	When You're Here, You're Dysfunctional Family Shares of Darden fall after the world's largest casual dining restaurant operator talked down its latest quarter and reduced its fiscal 2009 guidance.
The Motley Fool September 28, 2011 Rick Aristotle Munarriz	Food Fight at Darden When you're here, you're at the Olive Garden family.
The Motley Fool April 13, 2007 Ryan Fuhrmann	Rite Aid's Right-Size Ambitions If the retail pharmacy chain can improve its net margins, reduce debt, and smoothly integrate its latest acquisition, the stock's upside would be substantial.
The Motley Fool June 25, 2007 Ryan Fuhrmann	Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see.
The Motley Fool January 3, 2012 Shubh Datta	Bright Spots for Rite Aid Better same-store sales help Rite Aid trim losses.
The Motley Fool September 25, 2009 Chris Jones	The First Symptom of Health-Care Troubles? Rite Aid's problems imply bad news for consumers and the health-care system.
The Motley Fool July 6, 2004 Alyce Lomax	Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them.
The Motley Fool June 11, 2007 Mike Cianciolo	Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note.
The Motley Fool January 4, 2008 Timothy M. Otte	Drugstore Sales Droop in December The three major drugstore chains, Walgreen, CVS, and Rite Aid, all report soft sales for December.
The Motley Fool November 9, 2005 Steven Mallas	CVS Needs Rx for Cash The drugstore chain has the prescription for earnings growth, but investors need to keep an eye on free cash flow.
The Motley Fool October 11, 2007 Rick Aristotle Munarriz	Red Thursday, Ruby Tuesday The casual dining operator slips in a dud of a quarter. Investors, take note.
The Motley Fool December 17, 2004 Nathan Slaughter	Rock Lobster Darden posts strong Q2 gains with strength in both Red Lobster and Olive Garden.
The Motley Fool December 19, 2008 Rick Aristotle Munarriz	News You Can Chew On Restaurant news: Darden posts respectable results, but... Brinker completes a majority stake sale of Romano's Macaroni Grill... Carl's Jr. has a record-setting opening... Ark Restaurants suspends it's dividend... Value menu at Sonic... Ruby Tuesday... Buffalo Wild Wings...
The Motley Fool April 24, 2007 Rick Aristotle Munarriz	Eat at Woes The casual dining operator Brinker struggles through disappointing comps. Investors, take note.
The Motley Fool December 11, 2006 Matthew Crews	Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note.
The Motley Fool May 9, 2005 Timothy M. Otte	Flu Means All's Well for CVS Strong comp sales and benefits from the Eckerd acquisition drive CVS to a solid first quarter. Investors, take note.
The Motley Fool April 11, 2008 Ryan Fuhrmann	Rite Aid Hasn't Fully Recovered Rite Aid needs to be nursed back to health after its acquisition of Brooks Eckerd.
The Motley Fool October 5, 2004 Nathan Slaughter	Less of a Shine on Ruby Tuesday The restaurant chain meets Q1 earnings, but lowers guidance for fiscal 2005.
The Motley Fool September 22, 2006 Ryan Fuhrmann	More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note.
The Motley Fool April 7, 2004 Rick Aristotle Munarriz	Good Buy, Ruby Tuesday Casual dining's forgotten player is making some memorable moves.
The Motley Fool January 5, 2007 Matthew Crews	Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve.
The Motley Fool April 12, 2007 Rick Aristotle Munarriz	Clicking Those Ruby Slippers The casual dining operator clears the table in its fiscal third quarter.
The Motley Fool February 14, 2008 Timothy M. Otte	Darden Speaks Out Management optimism gives the restaurant company stock price a boost. Can it last?
The Motley Fool May 11, 2005 David Meier	O'Charley's Needs Some Luck The restaurant chain's stock falls on lowered expectations.
The Motley Fool November 29, 2011 Alyce Lomax	Rising Star Buy: Darden Restaurants It's time to invest in a cheap eatery with a conscience.
The Motley Fool June 24, 2005 Stephen D. Simpson	Is Rite Aid a Real Value Stock? Reality hasn't caught up with the company's turnaround prospects. Rite Aid must deal with a lot of debt and preferred equity if and when it recovers.
The Motley Fool June 23, 2004 Nathan Slaughter	Same Old Story at Darden Darden Restaurants closes out a mixed fiscal 2004.
The Motley Fool July 23, 2007 Markos Kaminis	Fool on the Street: Grilling Darden Restaurants Darden Restaurants, the largest casual dining chain operator in the world, wonders where to grow now.
The Motley Fool January 4, 2005 Seth Jayson	Rite Aid Still Needs First Aid Sales keep slacking for this tough turnaround. This doesn't mean investors should necessarily jump ship.
The Motley Fool April 9, 2007 Rich Duprey	Foolish Forecast: No Goodbye to Ruby Tuesday The casual dining restaurant appears to have a full plate for its 2007 third-quarter earnings report, which rolls out shortly. Investors, here is what you can expect to see.
The Motley Fool September 17, 2008 Alex Dumortier	Has a Run on Goldman and Morgan Begun? NYU economics professor Nouriel Roubini may have been right. We could very well be witnessing the death throes of the modern U.S. investment bank.
The Motley Fool June 20, 2007 Ryan Fuhrmann	Morgan Stanley Still Shining The brokerage house is riding high, with no signs of a slowdown. In less than two years, John Mack has turned Morgan from a chronic underperformer to the toast of Wall Street.
The Motley Fool March 20, 2007 Matt Koppenheffer	Foolish Forecast: Morgan Stanley Gets Ready to Deliver The financial firm will report it most recently quarterly earnings shortly. Investors, here is what you can expect to see.
The Motley Fool December 16, 2004 Nathan Slaughter	Rx: Get Some Earnings Quick The No. 3 drug chain Rite Aid posts a sharp drop in earnings and slashes guidance again.
The Motley Fool April 8, 2004 Seth Jayson	Rite Aid Wrings Out Profits Net store closings and comps increases bring black ink to the pharmacy's bottom line.
The Motley Fool September 7, 2004 Seth Jayson	Rejecting Rite Aid Shares of the drugstore chain droped 13%, and may prove to be a bargain if this is indeed a temporary slowdown and management can deliver more robust growth.
The Motley Fool April 26, 2005 Nathan Slaughter	Chili's: Leader of the Pack Restaurant operator Brinker tops third quarter earnings estimates on strength at Chili's.
The Motley Fool January 3, 2005 Nathan Slaughter	Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground.
The Motley Fool May 9, 2007 Rick Aristotle Munarriz	Who Wants These Bones? Darden Restaurants is looking to bury its Smokey Bones division.
The Motley Fool September 26, 2007 Ryan Fuhrmann	Foolish Forecast: Does Rite Aid Have the Right Rx? The retail pharmacy is set to release it second-quarter financial results. Investors, here is what you can expect to see.
The Motley Fool August 11, 2004 Nathan Slaughter	Brinker Takes Bite out of Outlook Chili's parent posts strong fourth-quarter earnings, but lowers guidance.
The Motley Fool September 29, 2011 Navjot Kaur	Should You Write Off Rite Aid? Rite Aid posts a relatively better quarter as wellness rewards the company.
The Motley Fool October 18, 2006 Seth Jayson	Swearing Off Chuck Does the market really need yet another restaurant chain? O'Charley's earnings downgrade is the least of investors' worries.
The Motley Fool December 19, 2003 Alyce Lomax	Darden: A Tough Sell Red Lobster is still the anchor around Darden Restaurants' neck.
The Motley Fool October 23, 2009 Rob Plaza	Maybe Customers Don't Want Their Baby Back Ribs Brinker serves up not-so appetizing results.
The Motley Fool September 21, 2006 Rick Aristotle Munarriz	Hungry for Shares At some restaurants, a buyback can make the bottom line go a long way. Darden isn't the only restaurant company swallowing its own shares. Investors, take note.
The Motley Fool July 8, 2009 Rick Aristotle Munarriz	Put Your Money Where Your Mouth Is Ruby Tuesday stock has quadrupled this year. Rival chains can't match that kind of price action, but they're no slackers, either.